Alecensa.com
| Top alec sites |
| Top ensa sites |
- Title
- ALECENSA® (alectinib) and ALK+ Non-Small Cell Lung Cancer
- Meta Description
- Learn about ALECENSA® (alectinib), an ALK+ metastatic non-small cell lung cancer treatment. Important Safety Information: What is the most important information I should know about ALECENSA? Everyone reacts differently to treatment with ALECENSA. It’s important to know the most serious and most common side effects with ALECENSA. Your doctor may lower the dose or stop treatment with ALECENSA if any side effects occur. Contact your doctor right away if you have any of the following side effects. ALECENSA may cause serious side effects, including: Liver problems (hepatotoxicity). ALECENSA may cause liver injury. Your doctor will do blood tests at least every 2 weeks for the first 3 months, and then 1 time each month and as needed during treatment with ALECENSA. Tell your doctor right away if you get any of the following signs and symptoms: Feeling tired, Feeling less hungry than usual, Yellowing of your skin or the whites of your eyes, Dark urine, Itchy skin, Nausea or vomiting, Pain ...
- Meta Keywords
- genentech, genentech biooncology, biooncology, alecensa, alectinib, alk-positive nsclc treatment, alk-positive non-small cell lung cancer medication, ALK+ NSCLC medication, ALK+ non-small cell lung cancer therapy, anaplastic lymphoma kinase, alectinib fda, alk inhibitor, alk cns metastasis
- Technologies in use
- Google Analytics, reCaptcha, jQuery, Font Awesome